You could not ask for a more positive catalyst than the Yahoo posted article on 2012 Financial Results and yet CUR declines. From this it is clear that nothing less than a home run is needed to move this stock around the bases. The 50,000 buy last night must have been a miss directed expectation that 110% positive outcomes would be recieved well by the traders of this stock. Very frustrating to say the least.
Even though today has been disappointing, I still think that there is a one-two punch coming very near future. I believe that we will see the announcement of a small partnership very soon and that the FDA will come out of nowhere one day and accelerate this ALS trial. Data seems positive, funds are in place and after hearing some of the testimony from this past month, there is no reason that the FDA will not give them the green light.
I don't think they need a "home run" (in terms of news), but they need more than what they put out there today. Late yesterday CUR rallied strongly (the 50k share buy you mentioned, actually I think it was bigger than that... about 150k in the last 10 minutes of trading). But in hindsight that was probably because it leaked that there would be "news" today. However, today's "news", that CUR anticipates starting a trial in South Korea, clearly isn't what would be expected to drive CUR a lot higher. So it's already pulled back. Nothing wrong with anticipating a real catalyst here, but this unfortunately wasn't it.
What the company needs now is actual things to happen, not just talk about future things. We need phase 1 data out there for people to see. we need the partnership deal in Mexico inked. We need solid info on the ALS phase 2 trial. we need the stroke trial to actually get started. Everything in pr's so far talk about things right around the corner. when actual events happen this will excite the investors. GLTA